qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer.

qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat. 2022 Jan; 191(2):335-344.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
China
DNA
Female
Homologous Recombination
Humans
Neoadjuvant Therapy
Platinum
Retrospective Studies
Triple Negative Breast Neoplasms

authors with profiles

Philip P. Connell